Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Christadoss

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Cellular Immunology|October 1, 1984
Suppression of cellular and humoral immunity to T-dependent antigens by calorie restrictionP Christadoss, N Talal, J Lindstrom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 1997
Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravisB Wu, C Deng, E Goluszko, et al.
Immunogenetics|January 1, 1990
Ek alpha transgene in B10 mice suppresses the development of myasthenia gravisP Christadoss, C S David, M Shenoy, et al.
Clinical Immunology and Immunopathology|March 1, 1993
Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptorM Shenoy, M Oshima, M Z Atassi, et al.
Clinical Immunology and Immunopathology|March 1, 1995
Human recombinant IL-2 augments immunoglobulin and induces rheumatoid factor production by rheumatoid arthritis lymphocytes engrafted into severe combined immunodeficient miceR Kaul, A Sharma, J R Lisse, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal toleranceP Christadoss, M Shenoy, M Oshima, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995
IFN-alpha treatment suppresses the development of experimental autoimmune myasthenia gravisM Shenoy, S Baron, B Wu, et al.
Immunogenetics|January 1, 1985
Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravisP Christadoss, J M Lindstrom, R W Melvold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1994
Effect of MHC class I and CD8 cell deficiency on experimental autoimmune myasthenia gravis pathogenesisM Shenoy, R Kaul, E Goluszko, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strainsB Wu, M Shenoy, E Goluszko, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Cellular Immunology|October 1, 1984
Suppression of cellular and humoral immunity to T-dependent antigens by calorie restrictionP Christadoss, N Talal, J Lindstrom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 1997
Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravisB Wu, C Deng, E Goluszko, et al.
Immunogenetics|January 1, 1990
Ek alpha transgene in B10 mice suppresses the development of myasthenia gravisP Christadoss, C S David, M Shenoy, et al.
Clinical Immunology and Immunopathology|March 1, 1993
Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptorM Shenoy, M Oshima, M Z Atassi, et al.
Clinical Immunology and Immunopathology|March 1, 1995
Human recombinant IL-2 augments immunoglobulin and induces rheumatoid factor production by rheumatoid arthritis lymphocytes engrafted into severe combined immunodeficient miceR Kaul, A Sharma, J R Lisse, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal toleranceP Christadoss, M Shenoy, M Oshima, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995
IFN-alpha treatment suppresses the development of experimental autoimmune myasthenia gravisM Shenoy, S Baron, B Wu, et al.
Immunogenetics|January 1, 1985
Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravisP Christadoss, J M Lindstrom, R W Melvold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1994
Effect of MHC class I and CD8 cell deficiency on experimental autoimmune myasthenia gravis pathogenesisM Shenoy, R Kaul, E Goluszko, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strainsB Wu, M Shenoy, E Goluszko, et al.
Pageof 5